Esfandiari Farah, Green Ralph, Cotterman Rebecca F, Pogribny Igor P, James S Jill, Miller Joshua W
University of California Davis, School of Medicine, Department of Medical Pathology, Research 3, Room 3200A, 4645 Second Avenue, Sacramento, CA 95817, USA.
Carcinogenesis. 2003 Dec;24(12):1935-40. doi: 10.1093/carcin/bgg163. Epub 2003 Aug 29.
MeCP2 is a member of a family of proteins [methyl- (cytosine-guanine)CpG-binding proteins] that bind specifically to methylated DNA and induce chromatin remodeling and gene silencing. Dietary deficiency of folate, choline and methionine causes decreased tissue S-adenosylmethionine concentrations (methyl deficiency), global DNA hypomethylation, hepatic steatosis, cirrhosis and ultimately hepatic tumorigenesis in rodents. We investigated the effects of this diet on expression of MeCP2 during pre-neoplastic transformation of liver tissue. After 9 weeks, MeCP2 mRNA level was slightly higher in methyl-deficient rats compared with replete controls, while after 36 weeks, a difference in MeCP2 mRNA level was no longer observed. In contrast, MeCP2 protein level was reduced almost 2-fold in the deficient rats compared with replete controls at both 9 and 36 weeks. Conversely, a second methyl-CpG-binding protein, MBD2, showed increased levels of both message and protein at the two time points. Low MeCP2 protein in the deficient rats was associated with a low level of the co-repressor protein, Sin3a, at 36 weeks. Moreover, a known gene target of MeCP2, the tumor suppressor gene metallothionein-I, was over-expressed in the deficient rat livers at both 9 and 36 weeks, suggesting that reduction in MeCP2 may have functional consequences. Methyl deficiency also caused an increase in the ratio of long to short variants of MeCP2 transcripts. This finding suggests that reduced MeCP2 protein level is the result of a reduced rate of translation. Reduction of MeCP2 protein expression may influence the initiation and/or progression of hepatic cancer induced by methyl deficiency and may provide a useful marker of pre-neoplastic change.
MeCP2是一类蛋白质家族(甲基化(胞嘧啶-鸟嘌呤)CpG结合蛋白)的成员,该家族蛋白特异性结合甲基化DNA并诱导染色质重塑和基因沉默。饮食中缺乏叶酸、胆碱和蛋氨酸会导致啮齿动物组织中S-腺苷甲硫氨酸浓度降低(甲基缺乏)、全基因组DNA低甲基化、肝脂肪变性、肝硬化并最终导致肝肿瘤发生。我们研究了这种饮食对肝组织肿瘤前转化过程中MeCP2表达的影响。9周后,与充足对照组相比,甲基缺乏大鼠的MeCP2 mRNA水平略高,而36周后,未观察到MeCP2 mRNA水平存在差异。相反,在9周和36周时,与充足对照组相比,缺乏组大鼠的MeCP2蛋白水平降低了近2倍。相反,另一种甲基-CpG结合蛋白MBD2在这两个时间点的mRNA和蛋白水平均升高。缺乏组大鼠中低水平的MeCP2蛋白与36周时共抑制蛋白Sin3a的低水平有关。此外,MeCP2的一个已知基因靶点,即肿瘤抑制基因金属硫蛋白-I,在9周和36周时在缺乏组大鼠肝脏中均过度表达,这表明MeCP2的减少可能具有功能后果。甲基缺乏还导致MeCP2转录本的长变体与短变体的比例增加。这一发现表明,MeCP2蛋白水平降低是翻译速率降低的结果。MeCP2蛋白表达的降低可能会影响甲基缺乏诱导的肝癌的发生和/或进展,并可能成为肿瘤前变化的有用标志物。